You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 132 No. 3, March 1978 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Measles Revaccination

Persistence and Degree of Antibody Titer by Type of Immune Response

Jaime Deseda-Tous, MD; James D. Cherry, MD; Mary J. Spencer, MD; Robert C. Welliver, MD; Kenneth M. Boyer, MD; James P. Dudley, MD; John M. Zahradnik, MD; Peter J. Krause, MD; Eric W. Walbergh

Am J Dis Child. 1978;132(3):287-290.


Abstract

• During a measles immunization campaign 203 children were enrolled in an antibody response study. Of this group, follow-up clinical data and sera samples were available from 125 children three weeks after immunization and from 90 children ten months later. Seventy-six of the children had been previously vaccinated, ten had a history of measles and 39 denied vaccination or illness. Twenty-six of the children had prevaccination hemagglutination inhibiting antibody titers of < 5. Of this group 12 had a primary immune response (IgM measles antibody) with geometric mean titers (GMT) of 90 and 40 three weeks and ten months respectively after vaccination. In contrast, the other 14 children with initial titers of < 5 had secondary immune responses (only IgG measles antibody) with GMTs of 28 and 9 three weeks and ten months after vaccination. Since the antibody responses in these children who had previously been stimulated by measles antigen were modest and transient, it is suggested that booster immunization may not be effective in preventing future secondary vaccine failures. Also noted in this study was a poor correlation between historical data and actual measles antibody.

(Am J Dis Child 132:287-290, 1978)



Author Affiliations

From the Department of Pediatrics, Division of Infectious Diseases, UCLA Center for the Health Sciences, Los Angeles.


Footnotes

Reprint requests to Department of Pediatrics, MDCC 22-442, UCLA Center for the Health Sciences, Los Angeles, CA 90024 (Dr Cherry).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Measles Reimmunization in Children Seronegative After Initial Immunization
Poland et al.
JAMA 1997;277:1156-1158.
ABSTRACT  

Age at and Time Since Vaccination During a Measles Outbreak in a Rural Community
Faust and Thompson
Arch Pediatr Adolesc Med 1983;137:977-980.
ABSTRACT  

A Clinical, Epidemiologic, Serologic, and Virologic Study of Influenza C Virus Infection
Dykes et al.
Arch Intern Med 1980;140:1295-1298.
ABSTRACT  

Measles-Specific Lymphocyte Reactivity and Serum Antibody in Subjects With Different Measles Histories
Krause et al.
Arch Pediatr Adolesc Med 1980;134:567-571.
ABSTRACT  

Measles Vaccination in Young Adults
PREBLUD et al.
ANN INTERN MED 1980;92:132-133.
ABSTRACT  

Epidemic Measles in Young Adults: Clinical, Epidemiologic, and Serologic Studies
KRAUSE et al.
ANN INTERN MED 1979;90:873-876.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.